Delaying surgery after neoadjuvant chemoradiotherapy improves prognosis of rectal cancer

被引:22
作者
Mihmanli, Mehmet [1 ]
Gurbulak, Esin Kabul [1 ]
Akgun, Ismail Ethem [1 ]
Celayir, Mustafa Fevzi [1 ]
Yazici, Pinar [1 ]
Tuncel, Deniz [2 ]
Bek, Tulin [3 ]
Oz, Ayhan [1 ]
Omeroglu, Sinan [1 ]
机构
[1] Sisli Etfal Training & Res Hosp, Dept Gen Surg, Halaskargazi Cad, TR-34371 Istanbul, Turkey
[2] Sisli Etfal Training & Res Hosp, Dept Pathol, TR-34371 Istanbul, Turkey
[3] Sisli Etfal Training & Res Hosp, Dept Radiat Oncol, TR-34371 Istanbul, Turkey
关键词
Rectal carcinoma; Pathological tumor response; Neoadjuvant chemoradiotherapy; Interval timing; Tumor down-staging; PATHOLOGICAL COMPLETE RESPONSE; TOTAL MESORECTAL EXCISION; PREOPERATIVE RADIATION-THERAPY; COMBINED-MODALITY THERAPY; TIME-INTERVAL; CHEMORADIATION THERAPY; TUMOR-REGRESSION; RANDOMIZED-TRIAL; RADIOTHERAPY; IMPACT;
D O I
10.4251/wjgo.v8.i9.695
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
AIM To investigate the prognostic effect of a delayed interval between neoadjuvant chemoradiotherapy (CRT) and surgery in locally advanced rectal cancer. METHODS We evaluated 87 patients with locally advanced mid-or distal rectal cancer undergoing total mesorectal excision following an interval period after neoadjuvant CRT at Sisli Hamidiye Etfal Training and Research Hospital, Istanbul between January 2009 and January 2014. Patients were divided into two groups according to the interval before surgery: < 8 wk (group.) and >= 8 wk (group.). Data related to patients, cancer characteristics and pathological examination were collected and analyzed. RESULTS When the distribution of timing between group. (n = 45) and group. (n = 42) was viewed, comparison of interval periods (median +/- SD) of groups showed a significant difference of as 5 +/- 1.28 wk in group. and 10.1 +/- 2.2 wk in group. (P < 0.001). The median follow-up period for all patients was 34.5 (9.9-81) mo. group. had significantly higher rates of pathological complete response (pCR) than group. had (19% vs 8.9%, P = 0.002). Rate of tumor regression grade (TRG) poor response was 44.4% in group. and 9.5% in group. (P < 0.002). A poor pathological response was associated with worse disease-free survival (P = 0.009). The interval time did not show any association with local recurrence (P = 0.79). CONCLUSION Delaying the neoadjuvant CRT-surgery interval may provide nodal down-staging, improve pCR rate, and decrease the rate of TRG poor response.
引用
收藏
页码:695 / 706
页数:12
相关论文
共 46 条
[11]   Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil or 5-fluorouracil and oxaliplatin on outcomes in rectal cancer [J].
Dolinsky, C. M. ;
Mahmoud, N. N. ;
Mick, R. ;
Sun, W. ;
Whittington, R. W. ;
Solin, L. J. ;
Haller, D. G. ;
Giantonio, B. J. ;
O'Dwyer, P. J. ;
Rosato, E. F. ;
Fry, R. D. ;
Metz, J. M. .
JOURNAL OF SURGICAL ONCOLOGY, 2007, 96 (03) :207-212
[12]   Timing of Surgery After Long-Course Neoadjuvant Chemoradiotherapy for Rectal Cancer: A Systematic Review of the Literature [J].
Foster, Jake D. ;
Jones, Emma L. ;
Falk, Stephen ;
Cooper, Edwin J. ;
Francis, Nader K. .
DISEASES OF THE COLON & RECTUM, 2013, 56 (07) :921-930
[13]   Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: The Lyon R90-01 randomized trial [J].
Francois, Y ;
Nemoz, CJ ;
Baulieux, J ;
Vignal, J ;
Grandjean, JP ;
Partensky, C ;
Souquet, JC ;
Adeleine, P ;
Gerard, JP .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (08) :2396-2402
[14]   Optimal Timing of Surgery After Chemoradiation for Advanced Rectal Cancer: Preliminary Results of a Multicenter, Nonrandomized Phase II Prospective Trial [J].
Garcia-Aguilar, Julio ;
Smith, David D. ;
Avila, Karin ;
Bergsland, Emily K. ;
Chu, Peiguo ;
Krieg, Richard M. .
ANNALS OF SURGERY, 2011, 254 (01) :97-102
[15]   Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers:: Results of FFCD 9203 [J].
Gerard, Jean-Pierre ;
Conroy, Thierry ;
Bonnetain, Franck ;
Bouche, Olivier ;
Chapet, Olivier ;
Closon-Dejardin, Marie-Therese ;
Untereiner, Michel ;
Leduc, Bernard ;
Francois, Eric ;
Maurel, Jean ;
Seitz, Jean-Francois ;
Buecher, Bruno ;
Mackiewicz, Remy ;
Ducreux, Michel ;
Bedenne, Laurent .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (28) :4620-4625
[16]   Long-term results of the Lyons R90-01 randomized trial of preoperative radiotherapy with delayed surgery and its effect on sphincter-saving surgery in rectal cancer [J].
Glehen, O ;
Chapet, O ;
Adham, M ;
Nemoz, JC ;
Gerard, JP .
BRITISH JOURNAL OF SURGERY, 2003, 90 (08) :996-998
[17]   Optimal time intervals between pre-operative radiotherapy or chemoradiotherapy and surgery in rectal cancer? [J].
Glimelius, Bengt .
FRONTIERS IN ONCOLOGY, 2014, 4
[18]   Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer [J].
Guillem, JG ;
Chessin, DB ;
Cohen, AM ;
Shia, J ;
Mazumdar, M ;
Enker, W ;
Paty, PB ;
Weiser, MR ;
Klimstra, D ;
Saltz, L ;
Minsky, BD ;
Wong, WD .
ANNALS OF SURGERY, 2005, 241 (05) :829-838
[19]   Rectal cancer - The Basingstoke experience of total mesorectal excision, 1978-1997 [J].
Heald, RJ ;
Moran, BJ ;
Ryall, RDH ;
Sexton, R ;
MacFarlane, JK .
ARCHIVES OF SURGERY, 1998, 133 (08) :894-898
[20]   THE MESORECTUM IN RECTAL-CANCER SURGERY - THE CLUE TO PELVIC RECURRENCE [J].
HEALD, RJ ;
HUSBAND, EM ;
RYALL, RDH .
BRITISH JOURNAL OF SURGERY, 1982, 69 (10) :613-616